Research and Development

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …

Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …

SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …

Sanofi-Aventis will now just be known as Sanofi after the French pharma company’s shareholders agreed to change its name. Following …

Vienna-based biotech Intercell has appointed Thomas Lingelbach as chief executive with effect from 10 May. He has more than twenty …

Two contract research organisations INC Research and Kendle International are to merge to create a new major player in the …

Sanofi-Aventis has signed a research deal with the Medicines for Malaria Venture charity. They will work together to identify, characterise …